Truthout
Drug Pricing
Trump Has Been Giving Up Ground in His Much-Vaunted “Trade War”
The president is losing his trade war badly, and that is a good thing for people in the United States and the world.
We Need a Public Option in the Pharmaceutical Industry
Public ownership can ensure long-term, affordable access to essential medication.
Big Pharma Invests Millions as Congress Prepares Drug Pricing Bills
Pharmaceutical companies are writing large checks to key lawmakers and spending millions on ad buying and lobbying.
Removing the Profit From Our Pills: The Case for a Public Pharma System
Vital safety and health services should be entrusted to institutions that are publicly accountable.
Pelosi’s Plan Is Not Enough. Lower Drug Prices Now Through a Public Option.
Pelosi released the “Lower Drug Costs Now Act” on September 19.
Government-Granted Patent Monopolies Are Driving Up Drug Prices
Without monopolies, drugs are cheap to make and there's no incentive to lie about their benefits and harms.
Trump Promises a “Phenomenal” Health Plan. What Does That Mean?
Likely elements of the plan are already in plain sight -- in executive actions and in the president’s budget proposal.
Pharma Cash Rolls Into Congress to Defend an Embattled Industry
Mitch McConnell, who is running for reelection, has seen an uptick in pharmaceutical industry donations this year.
Insulin Prices Killed Josh Wilkerson. Now His Mother Is Taking On Big Pharma.
“My son died at 27 because his income was insufficient for him to purchase insulin,” says Erin Weaver.
Drugmakers Master Rolling Out Their Own Generics to Stifle Competition
Big brand companies producing authorized generics maximize their profits by appearing to compete with themselves.